Overview

Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This investigation is intended to collect safety information for the technique of mixing cefazolin in the CRRT solution on the CRRT circuit, the patient, in addition to collecting information regarding the ability to obtain therapeutic cefazolin serum concentrations
Phase:
Phase 1
Details
Lead Sponsor:
Drexel University
Collaborator:
The Center for Pediatric Pharmacotherapy
Treatments:
Cefazolin
Pharmaceutical Solutions